MassDevice

Orchestra BioMed enrolls first patient in Sirolumus AngioInfusion balloon trial

Orchestra BioMed (Nasdaq:OBIO) today announced the first patient enrollments in a study of its Virtue Sirolimus AngioInfusion ...